Asia

Indonesia approves Sinopharm Covid-19 vaccine for emergency use

JAKARTA (REUTERS) – Indonesia’s drug regulator on Friday (April 30) approved a Covid-19 vaccine produced by China’s Sinopharm, which is due to be used in a private vaccination scheme under which companies can buy government-procured vaccines to inoculate their staff.

No detailed efficacy data of Sinopharm’s vaccine has been publicly released, but its developer, Beijing Biological Products Institute, a unit of Sinopharm subsidiary China National Biotec Group (CNBG), said the vaccine was 79.34 per cent effective in preventing people from developing the disease, based on interim data.

This is a developing story.

Join ST’s Telegram channel here and get the latest breaking news delivered to you.

Source: Read Full Article